AR

Abhishek Rakesh Yadav

Active Director Designated Partner DIN 11412327
DIN 11412327 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhishek Rakesh Yadav

Data last updated:

Abhishek Rakesh Yadav is a Designated Partner at Vitanexa Pharma Llp (since 2025).

DIN 11412327
Primary Designation Designated Partner
First Appointment 06 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Dec 20252025Active

Board colleagues of Abhishek Rakesh Yadav

NameDINCompanyDesignation
Akhilendra Pratap Singh11412328Vitanexa Pharma LlpDesignated Partner
Arvind Kumar Singh11412326Vitanexa Pharma LlpDesignated Partner
Sitaram N Singh11412325Vitanexa Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vitanexa Pharma Llp
Premium access

Shareholding and investment profile for Abhishek Rakesh Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Rakesh Yadav

Abhishek Rakesh Yadav currently holds 1 directorship: Vitanexa Pharma Llp (Designated Partner, since 06 Dec 2025).

Abhishek Rakesh Yadav was first appointed on 06 Dec 2025 as Designated Partner at Vitanexa Pharma Llp.

The current boards of Abhishek Rakesh Yadav's companies include Akhilendra Pratap Singh (Vitanexa Pharma Llp), Arvind Kumar Singh (Vitanexa Pharma Llp), Sitaram N Singh (Vitanexa Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available